COCP — Cocrystal Pharma Share News
0.000.00%
Last trade - 00:00Cocrystal Pharma Inc reports results for the quarter ended June 30 - Earnings Summary
Cocrystal Pharma Inc expected to post a loss of 16 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Medtronic, Macy's, USA Rare Earth
U.S. STOCKS ON THE MOVE-USA Rare Earth, MiniMed, Rent the Runway
U.S. STOCKS ON THE MOVE-Ollie's Bargain Outlet Holdings, Steel Dynamics
Cocrystal Pharma up after appointing James Sapirstein as CEO
Brief: Cocrystal Pharma Appoints James Sapirstein, Biopharma Industry Leader With Extensive Antiviral Development Experience, As Chief Executive Officer
Brief: Cocrystal Pharma Inc - Files To Offer Up To $150 Million In Securities - SEC Filing
U.S. STOCKS ON THE MOVE-Tesla, Blue Owl, Ford
Cocrystal Pharma soars as FDA fast-tracks oral norovirus drug
U.S. STOCKS ON THE MOVE-Energy firms, Estee Lauder, HMH Holding
Cocrystal Pharma rises as FDA fast-tracks oral norovirus drug
Cocrystal Pharma 2025 net loss narrows as R&D expenses fall
Brief: Cocrystal Pharma FY Net Income USD -8.831 Million
Brief: Cocrystal Pharma Receives Irb Approval From Emory University School Of Medicine
Cocrystal Pharma Q3 loss narrows
Brief: Cocrystal Pharma Announces Closing Of Up To $13 Million Registered Direct Offering
Brief: Cocrystal Pharma Announces Up To $13 Mln Direct Offering Priced At-Market Under Nasdaq Rules
Cocrystal Pharma soars on oral norovirus drug progress